$454.54
1.24%
NYSE, Nov 16, 11:28 am EST. Market open.

Waters Stock price

$460.25
+31.08 7.24% 1M
+125.32 37.42% 6M
+80.42 21.17% YTD
+80.95 21.34% 1Y
+209.27 83.38% 3Y
+114.61 33.16% 5Y
+320.07 228.33% 10Y
+409.65 809.59% 20Y
NYSE, Closing price Fri, Nov 13 2026
-1.95 0.42%

AI Insights on Waters Insights AI Insights on Waters

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Waters a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.

Key metrics

Basic
Market capitalization
$44.7b
Enterprise Value
$49.2b
Net debt
$4.5b
Cash
$539.0m
Shares outstanding
98.2m
Valuation
P/E
272.3
P/S | estimate
9.6 | 6.8
EV/Sales | estimate
10.6 | 7.5
EV/FCF | ex SBC
123.6 | 151.4
P/B
2.9
Financial Health
Equity Ratio
50.5%
Return on Equity
25.1%
ROCE
2.3%
ROIC
1.9%
Debt/Equity
0.3
Share-Based Compensation & Dilution
SBC | % of Revenue
$73.2m | 1.6%
SBC as % of FCF
18.4%
SBC Growth 1Y
51.3%
Share Count Growth 1Y
65.1%
Shareholder Yield
-65.1%
Financials
Revenue | estimate
$4.6b | $6.6b
EBITDA
$938.8m
EBIT
$518.6m
Net Income
$166.1m
Free Cash Flow | ex SBC
$398.5m | $325.3m
Growth
Revenue | estimate
52.5% | 107.0%
EBITDA
5.4%
EBIT
-38.5%
Net Income
-74.9%
Free Cash Flow
-35.7%
Margin
Gross
50.9%
EBITDA
20.2%
EBIT
11.2%
Net
3.6%
Free Cash Flow | ex SBC
8.6% | 7.0%
More
EPS
$1.7
FCF per Share
$4.1
Short interest
3.4%
Employees
8k
Rev per Employee
$400.0k

Waters Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Waters forecast:

21x Buy
75%
7x Hold
25%

Analyst Opinions

28 Analysts have issued a Waters forecast:

Buy
75%
Hold
25%

Waters Events

Past Events
NOV
3
Q3 2026 Earnings Call
13 days ago
SEP
23
U.S. All Stars Conference
about 2 months ago
SEP
9
Wells Fargo 21st Annual Healthcare Conference
2 months ago
AUG
4
Q2 2026 Earnings Call
3 months ago
JUN
3
Jefferies Global Healthcare Conference 2026
6 months ago
MAY
5
Q1 2026 Earnings Call
7 months ago
MAR
2
TD Cowen 46th Annual Health Care Conference
9 months ago
FEB
9
Q4 2025 Earnings Call
9 months ago
JAN
12
44th Annual J.P. Morgan Healthcare Conference
10 months ago
NOV
18
Jefferies London Healthcare Conference 2025
12 months ago
NOV
4
Q3 2025 Earnings Call
about one year ago

Financial data from Waters

Jul '26
+/-
%
4,644 4,644
52% 52%
100%
- Direct Costs 2,281 2,281
83% 83%
49%
2,364 2,364
31% 31%
51%
- Selling and Administrative Expenses 1,106 1,106
54% 54%
24%
- Research and Development Expense 319 319
70% 70%
7%
939 939
5% 5%
20%
- Depreciation and Amortization 420 420
792% 792%
9%
EBIT (Operating Income) EBIT 519 519
39% 39%
11%
Net Profit 166 166
75% 75%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Waters directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Waters Stock News

Neutral
PRNewsWire
●
6 days ago
BD OneFlow™ LST and BD OneFlow™ B-CLPD T1 Tests now FDA 510(k)-cleared in U.S. for identifying B-cell non-Hodgkin lymphoma (NHL) Delivers 96.3% sensitivity and 98.2% specificity1 in identifying chronic lymphocytic leukemia (CLL), one of the most common types of NHL All-in-one solution reduces 95% of manual steps,2 delivering workflow efficiency, fast turnaround times, and a reduction in errors ...
Neutral
PRNewsWire
●
13 days ago
Company to Provide Starting 2027 Growth Framework on Earnings Conference Call Third Quarter 2026 Highlights Total reported revenue of $1.767 billion exceeded guidance midpoint by $14 million, led by organic revenue growth of 9% as reported and 10% in constant currency, with acquired business revenue landing slightly ahead of guidance. GAAP EPS of $0.82; Adjusted EPS of $4.10 grew 21% and exceed...
More Waters News

Company Profile

Waters Corp. is a measurement company, which engages in the analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations. It operates through Waters and TA segments. The Waters segment designs, manufactures, distributes and services liquid chromatography and ultra performance liquid chromatography instruments, columns and other chemistry consumables that can be integrated and used along with other analytical instruments. The TA Instruments segment designs, manufactures, distributes and services thermal analysis, rheometry and calorimetry instruments. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.

Head office United States
CEO Dr. Batra
Employees 7,900
Founded 1958
Website www.waters.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today